SIEN stock forecast
Our latest prediction for Sientra, Inc.'s stock price was made on the Feb. 20, 2020 when the stock price was at 5.93$.
In the short term (2weeks), SIEN's stock price should underperform the market by -3.43%. During that period the price should oscillate between -10.51% and +11.50%.
In the medium term (3months), SIEN's stock price should underperform the market by -6.59%. During that period the price should oscillate between -41.30% and +31.04%.Get email alerts
Create a solid portfolio with SIEN
About Sientra, Inc.
Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. It operates through two reportable segments: Breast Products and miraDry. The Breast Products segment focuses on sales of its breast implants, tissue expanders and scar management products under the brands Sientra, AlloX2, Dermaspan, Softspan and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System, consisting of a console and a handheld device which uses consumable single-use bioTips. The company was founded by Hani M. Zeini on August 29, 2003 and is headquartered in Santa Barbara, CA.
At the moment the company generates 80M USD in revenues.
On its last earning announcement, the company reported a loss of -3.16$ per share.
The book value per share is 3.62$
Three months stock forecastFeb. 20, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|